德州什么原因引起的儿童癫痫病(泰安治癫痫病那家医院好) (今日更新中)

BEIJING, Jan. 3 (Xinhua) -- China's building materials showed different momentum of growth in November 2011, with a slowing cement output growth and a speeding plate glass, according to latest statistics from the country's top economic planner.Cement output growth in November 2011 stood at 11.2 percent year-on-year, 6.1 percentage points lower than previous year, while plate glass production expansion reached 7.1 percent year-on-year, quickening by by 0.5 percentage points from previous year.Still, China's cement output reached 1.89 trillion tonnes in the first 11 months of last year, an increase 17.2 percent year-on-year, 1.6 percentage points faster than previous year.The output of flat glass, a sector fraught with overcapacity and duplicated construction problems, rose 17 percent year-on-year to 6.82 trillion weight boxes in the January-November period of last year, according to the NDRC.Profits of China's building materials industry surged 53.1 percent year-on-year to 243.7 billion yuan (38.68 billion U.S. dollars) in the first 11 months of 2011.To curb the overcapacity and repeated construction in the flat glass sector, the NDRC said in a statement in October 2011 that it would take move nationwide to clear up projects for construction of flat glass production facilities.

WUHAN, Oct. 8 (Xinhua) -- A museum that honors the 1911 Revolution, also known as the Xinhai Revolution, reopened Saturday after renovation to commemorate the centenary of the uprising at Wuchang in central Hubei province.More than 200 items that illustrate the revolution, such as photos, telegraphs, models and and simulative historic scenes, are on display.Located near the famous Yellow Crane Tower, the museum was once the headquarters of the revolutionary army.The movement's leader, Sun Yat-sen, overturned the ruling Qing Dynasty (1644-1911) after the revolution on Oct. 10, 1911 and founded the Republic of China in 1912.Commemorative gatherings were also held in provinces of Guangdong, where Sun was born, and Jiangsu, where the capital of the Republic of China was located.

UNITED NATIONS, Nov. 21 (Xinhua) -- Dramatic progress in science, political leadership, and results indicate that 2011 was a "game changing" year for the international AIDS response, and much progress has been made in 2011 to check AIDS-related deaths since 1997, the peak of the epidemic, a new report released by the Joint United Nations Program on HIV/AIDS (UNAIDS) said on Monday."The Report on the Global AIDS Epidemic 2011" found that new infections were reduced by 21 percent since 1997, and deaths from AIDS-related illnesses decreased by 21 percent since 2005, according to the report.Furthermore, 47 percent (6.6 million) of the estimated 14.2 million people eligible for antiretroviral therapy treatment in low- and middle-income countries were accessing treatment, in increase of 1.35 million people since 2009.The report also found early signs that HIV treatment is having an impact on reducing the number of new HIV infections. As treatment reduces the viral load of a person living HIV to almost undetectable levels, it also reduces the risk of transmitting the virus to an uninfected partner, according to the report. Studies also show that treatment can be up to 96 percent effective in preventing HIV transmission among couples.Eleven countries, including many Sub-Saharan African countries, reached "close to universal access" for AIDS treatment, which is determined to be 80 percent access, in 2011.Botswana made the most dramatic progress in scaling up access to treatment, the report said. While sexual patterns remained relatively stable in the country since 2000, access to treatment increased from less than 5 percent in 2000 to more than 80 percent in 2011.Despite progress, however, the report does note that 2011 marks an unprecedented high the number of people infected with HIV worldwide.Globally, an estimated 34 million people are currently living with the infection. Approximately 2.7 million got infected with the virus in 2010, and as many as 1.8 million people died of AIDS- related illnesses in 2010.Yet the report also notes estimates that as many as 2.5 million deaths are estimated to have been averted in low- and middle- income countries due to increased access to HIV treatment since 1995."Now is not the time to reduce our efforts despite some good news on reducing new infections. Infections are decreasing, but not rapidly enough," said Kim Nichols, executive director of African Services Committee, on Monday at a press conference."There are fewer AIDS deaths, but with the number of infections increasing, prevention has to be the mainstay of our response," Nichols said.Indeed, the UNAIDS report calls for a new framework for investments which are focused on "high-impact, evidence-based, high-value strategies," according to a press release from the UNAIDS website.The framework, which aims to achieve universal access to treatment and prevention centers by 2015, requires a 22-24 billion US dollar funding increase by 2015.Given the withering state of the global economy -- donor funding for the AIDS response has dropped from 7.6 billion in 2009 to 6.9 billion in 2010 -- raising that kind of money may be a long shot. Regardless, UNAIDS'new investment plan calls for smarter uses of less money.According to the report, the framework will focus on high-risk populations like sex workers, men who have sex with men, and people who inject drugs and prevent infections among children, as well as invest in behavior change programs, condom promotion, and treatment, care and support for people living with HIV."The world faces a clear choice: maintain current efforts and make incremental progress, or invest smartly and achieve rapid success in the AIDS response," says the UNAIDS report.

BEIJING, Oct. 13 (Xinhuanet) -- Himalayas may be one of the most potential regions to provide solar power in future, according to a new research by Japanese scientists quoted by media reports Thursday. Deserts are usually regarded as the hotbeds for capturing solar power, but some of the loftiest and coldest regions can receive more energy from the sun than some deserts, said Takashi Oozeki and Yutaka Genchi, authors of the research published in Environmental Science and Technology. To set up solar cells on Himalayas would be challenging. Transmission losses and snowfall should be taken into consideration, said the researchers with the National Institute of Industrial Science and Technology in Japan. Still, the Himalayan region is attractive, because there are large energy demands in the countries nearby."It is near regions with large future energy demands such as China and India," they said.Other cold regions that can receive solar power include Andes of South America and Antarctica, according to the study.

WASHINGTON, Jan. 19 (Xinhua) -- New research published this week in Nature Medicine indicates that targeted drugs such as gefitinib might more effectively treat non-small cell lung cancer if they could be combined with agents that block certain microRNAs.The study, led by investigators with the Ohio State University Comprehensive Cancer Center, shows that overexpression of two genes called MET and EGFR causes the deregulation of six microRNAs, and that this deregulation leads to gefitinib resistance.The findings support the development of agents that restore the levels of these microRNAs. It offers a new strategy for treating non-small cell lung cancer, which is responsible for about 85 percent of the 221,000 lung-cancer cases and 157,000 deaths that occur annually in the United States. It also suggests that measuring the expression levels of certain microRNAs -- those controlled by the MET gene -- might predict which lung-cancer cases are likely to be resistant to gefitinib.Epidermal growth factor receptor (EGFR) is frequently overexpressed in non-small cell lung cancer, and this leads to uncontrolled cell proliferation. Gefitinib selectively inhibits EGFR activation and triggers cancer cells to self-destruct by apoptosis. However, non-small cell lung cancer cells inevitably develop resistance to the drug. The study reveals how this resistance occurs."Our findings suggest that gefitinib resistance that is caused by MET overexpression is at least partly due to miRNA deregulation, " says principal investigator Carlo Croce.

来源：资阳报